A patent related to T-ignite® technology granted in Canada

September 14th, 2022 | Press Release

A patent for UI-101 and UI-201 (CA2925658 A1, “T cell inducing vaccine containing an inter-epitope sequence that promotes antigen presentation”), which we hold an exclusive license, was granted in Canada. The family patents have been also issued in the US（US11179450）and Japan (JP6558699).

Back to Press releases

We want to provide you with the most important information and services in the best possible way. In order to do this, we need your consent to use the web analysis tool »Google Analytics« to create and evaluate an anonymous analysis of your visit for statistical purposes. You can change your consent at any time on the data protection page, otherwise it will remain valid for twelve months.